Programmed cell death protein 1 is a marker for neoadjuvant chemotherapy response in triple-negative breast cancer

OBJECTIVE: Tumor-infiltrating lymphocytes are detectable in up to 75% of triple-negative breast cancer. The composition of these infiltrates may influence prognosis and is not known regarding regulatory or effector lymphocytes. The objectives of this study were to describe and quantify the compositi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaui, Maria de Fátima Dias, Amendola, Luis Claudio, Quintella, Danielle Carvalho, Canedo, Nathalie, Bonomo, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Médica Brasileira 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508899/
https://www.ncbi.nlm.nih.gov/pubmed/37729362
http://dx.doi.org/10.1590/1806-9282.20230276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508899/
https://www.ncbi.nlm.nih.gov/pubmed/37729362
http://dx.doi.org/10.1590/1806-9282.20230276

Ejemplares similares